Skip to main content
. 2017 Oct 23;8(19):4057–4064. doi: 10.7150/jca.21365

Figure 3.

Figure 3

Hazard rate (HR) for tumor recurrence over time for node-positive (N+; solid lines) and node-negative (N-; dashed lines) with stratification according to (A) T factors, (B) adjuvant chemotherapy or surgery alone, (C) gender, and (D) degree of lymph node dissection.